Back to Dulaglutide research
dulaglutide gip agonist other 2016-05-11 ClinicalTrials

Tirzepatide's Early Safety and Drug Profile Explored in Diabetes Study

A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

Abstract

A Single- and Multiple-Ascending Dose Study in Healthy Subjects to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3298176 and Multiple Doses in Patients With Type 2 Diabetes Mellitus NCT ID: NCT02759107 S…

dulaglutide tirzepatide gip agonist glp 1 agonist protocol relevant safety data present
Source: clinicaltrials:NCT02759107 · Ingested 2026-04-03 · Digest: gemini-2.5-flash